Insider Trading & Ownership - NovoCure Ltd (NVCR)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for NovoCure Ltd
Goto 0, 1, 2, ...8, 9, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-01
Sale
2024-03-05
4:09 pm
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
3,324$16.02$53,253251,235
(Direct)
View
2024-03-01
Sale
2024-03-05
4:08 pm
NovoCure LtdNVCRLeonard Frank X
EVP, Pres., Novocure Oncology
2,519$16.02$40,358160,098
(Direct)
View
2024-02-28
Sale
2024-02-29
4:38 pm
NovoCure LtdNVCRLeonard Frank X
EVP, Pres., Novocure Oncology
2,078$16.14$33,545318,965
(Direct)
View
2024-02-28
Sale
2024-02-29
4:28 pm
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
2,303$16.14$37,177326,479
(Direct)
View
2023-11-07
Sale
2023-11-08
4:22 pm
NovoCure LtdNVCRShah Pritesh
Chief Growth Officer
382$12.65$4,832124,511
(Direct)
View
2023-09-01
Sale
2023-09-05
4:24 pm
NovoCure LtdNVCRCordova Ashley
Chief Financial Officer
883$21.82$19,26599,650
(Direct)
View
2023-09-01
Sale
2023-09-05
4:24 pm
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
294$21.82$6,414209,825
(Direct)
View
2023-09-01
Sale
2023-09-05
4:23 pm
NovoCure LtdNVCRShah Pritesh
Chief Growth Officer
273$21.82$5,956124,893
(Direct)
View
2023-08-02
Sale
2023-08-04
4:02 pm
NovoCure LtdNVCRCordova Ashley
Chief Financial Officer
1,144$30.25$34,607100,533
(Direct)
View
2023-03-03
Sale
2023-03-07
4:52 pm
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
13,609$75.55$1,028,16554,284
(Direct)
View
2023-03-03
Sale
2023-03-07
4:52 pm
NovoCure LtdNVCRShah Pritesh
Chief Growth Officer
21,421$76.16$1,631,411124,799
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-27
Option Award
2024-02-29
4:43 pm
2025-02-27
2034-02-26
NovoCure LtdNVCRCordova Ashley
Chief Financial Officer
258,597$16.3376,215
(Direct)
View
2024-02-27
Option Award
2024-02-29
4:38 pm
2025-02-27
2034-02-26
NovoCure LtdNVCRLeonard Frank X
EVP, Pres., Novocure Oncology
258,597$16.3318,965
(Direct)
View
2024-02-27
Option Award
2024-02-29
4:36 pm
2025-02-27
2034-02-26
NovoCure LtdNVCRPuri Michal Nath
Chief Human Resources Officer
181,017$16.3218,610
(Direct)
View
2024-02-27
Option Award
2024-02-29
4:35 pm
2025-02-27
2034-02-26
NovoCure LtdNVCRWeinberg Uri
Chief Innovation Officer
206,877$16.3296,226
(Direct)
View
2024-02-27
Option Award
2024-02-29
4:33 pm
2025-02-27
2034-02-26
NovoCure LtdNVCRLeupin Nicolas
Chief Medical Officer
129,298$16.3129,298
(Direct)
View
2024-02-27
Option Award
2024-02-29
4:33 pm
2025-02-27
2034-02-26
NovoCure LtdNVCRGiladi Moshe
Chief Science Officer
129,298$16.3147,945
(Direct)
View
2023-12-31
Option Award
2024-02-29
4:30 pm
N/A
N/A
NovoCure LtdNVCRBen Arye Barak
General Counsel
128$12.69242,200
(Direct)
View
2024-02-27
Option Award
2024-02-29
4:30 pm
2025-02-27
2034-02-26
NovoCure LtdNVCRBen Arye Barak
General Counsel
206,877$16.3242,200
(Direct)
View
2023-12-31
Option Award
2024-02-29
4:28 pm
N/A
N/A
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
3$12.69326,479
(Direct)
View
2024-02-27
Option Award
2024-02-29
4:28 pm
2025-02-27
2034-02-26
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
118,954$16.3326,479
(Direct)
View

Ownership
2024-01-12
4:57 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
EVP, Pres., Novocure Oncology
0$0227,173
(Direct)
View

Ownership
2023-12-20
4:23 pm
N/A
N/A
NovoCure LtdNVCRGiladi Moshe
Chief Science Officer
0$061,032
(Direct)
View
2023-10-31
Option Award
2023-11-03
4:08 pm
N/A
N/A
NovoCure LtdNVCRPuri Michal Nath
Chief Human Resources Officer
37,593$095,197
(Direct)
View
2023-10-31
Option Award
2023-11-03
4:08 pm
2024-10-31
2033-10-30
NovoCure LtdNVCRPuri Michal Nath
Chief Human Resources Officer
57,604$13.395,197
(Direct)
View
2023-10-31
Exercise
2023-11-02
4:20 pm
N/A
N/A
NovoCure LtdNVCRCordova Ashley
Chief Financial Officer
7,736$11.46117,793
(Direct)
View
2023-10-31
Exercise
2023-11-02
4:20 pm
N/A
N/A
NovoCure LtdNVCRCordova Ashley
Chief Financial Officer
2,480$11.44117,793
(Direct)
View
2023-10-31
Exercise
2023-11-02
4:20 pm
N/A
2026-02-24
NovoCure LtdNVCRCordova Ashley
Chief Financial Officer
17,968$0117,793
(Direct)
View
2023-10-31
Exercise
2023-11-02
4:20 pm
N/A
N/A
NovoCure LtdNVCRCordova Ashley
Chief Financial Officer
7,752$7.15117,793
(Direct)
View
2023-06-30
Option Award
2023-07-06
4:15 pm
N/A
N/A
NovoCure LtdNVCRWeinberg Uri
Chief Innovation Officer
305$35.2889,349
(Direct)
View
2023-06-30
Option Award
2023-07-06
4:14 pm
N/A
N/A
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
366$35.28210,119
(Direct)
View
2023-06-30
Option Award
2023-07-06
4:14 pm
N/A
N/A
NovoCure LtdNVCRShah Pritesh
Chief Growth Officer
367$35.28125,166
(Direct)
View
2023-06-30
Option Award
2023-07-06
4:14 pm
N/A
N/A
NovoCure LtdNVCRBurke William Patrick
Chief Human Resources Officer
357$35.2866,447
(Direct)
View
2023-06-30
Option Award
2023-07-06
4:13 pm
N/A
N/A
NovoCure LtdNVCRBen Arye Barak
General Counsel
288$35.2835,195
(Direct)
View
2023-06-30
Option Award
2023-07-06
4:13 pm
N/A
N/A
NovoCure LtdNVCRCordova Ashley
Chief Financial Officer
367$35.28101,677
(Direct)
View
2023-06-30
Option Award
2023-07-06
4:12 pm
N/A
N/A
NovoCure LtdNVCRDanziger Asaf
Chief Executive Officer
367$35.2813,989
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:05 pm
2024-06-07
2033-06-06
NovoCure LtdNVCRVERNON W ANTHONY
Director
10,130$0172,074
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:05 pm
2024-06-07
2033-06-06
NovoCure LtdNVCRScannell Timothy J
Director
10,130$010,205
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:04 pm
2024-06-07
2033-06-06
NovoCure LtdNVCRHung David
Director
12,554$012,554
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:04 pm
2024-06-07
2033-06-06
NovoCure LtdNVCRMadden Martin J.
Director
12,554$012,554
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:04 pm
2024-06-07
2033-06-06
NovoCure LtdNVCRLEUNG GABRIEL
Director
10,130$085,416
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:04 pm
2024-06-07
2033-06-06
NovoCure LtdNVCRHILLEMAN JERYL L
Director
12,554$012,554
(Direct)
View
2023-05-09
Option Award(A)
2023-05-17
4:58 pm
N/A
2033-05-08
NovoCure LtdNVCRStafford Kristin
Director
15,873$015,873
(Direct)
View
2023-05-09
Option Award
2023-05-11
4:34 pm
N/A
2033-05-08
NovoCure LtdNVCRStafford Kristin
Director
15,873$015,873
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, ...8, 9, Next